pd 169316 has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xiao, C | 1 |
Zhong, L | 1 |
Shan, Z | 1 |
Xu, T | 1 |
Gan, L | 1 |
Song, H | 1 |
Yang, R | 1 |
Li, L | 1 |
Liu, B | 1 |
1 other study available for pd 169316 and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Topics: Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neopl | 2016 |